Genzyme Corporation CEO Says Biotech Firm is Not for Sale- Wall Street Journal

December 6, 2007 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

NEW YORK (Reuters) - Biotechnology company Genzyme Corp (GENZ.O: Quote, Profile, Research) is not for sale, despite recent interest from financier Carl Icahn, the company's chief executive said in The Wall Street Journal on Thursday.

Twitter
LinkedIn
Facebook
Email
Print

Alliances Mergers & acquisitions